Copy Number Analysis via Quality Assessment and Statistical Confidence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic tools for determining gene copy numbers are limited by high false-positive rates and lack of comprehensive quality assessment, which can lead to inaccurate disease diagnosis and carrier status determination.

Innovation Solution

A method combining biological assays with quality assessment and statistical confidence analysis, using real-time PCR to analyze target loci normalized to reference loci, with quality control metrics and confidence thresholds to ensure accurate copy number calls.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If comprehensive quality assessment and statistical confidence analysis are implemented, then diagnostic accuracy is improved, but assay complexity increases

Engineering Contradiction:
Improvecopy number measurement accuracyVSAvoidassay system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The diagnostic process is segmented into distinct modules: biological assay execution, quality metric calculation, statistical confidence assessment, and copy number call determination. Each module processes specific aspects independently, allowing comprehensive analysis while maintaining manageable complexity through modular organization of assessment functions.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system implements feedback loops where quality metrics and statistical confidence levels are continuously calculated and used to adjust or validate copy number calls. This feedback mechanism ensures diagnostic accuracy by systematically evaluating assay performance and confidence levels before final interpretation.

Inventive Principle:
Principle #23Feedback

2Reliability

If multiple biological assays are performed with quality control metrics, then false-positive rate is reduced, but time consumption increases

Engineering Contradiction:
Improvediagnostic reliabilityVSAvoidassay execution time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

Quality control metrics and statistical parameters are calculated in advance during the assay execution process, before final copy number determination. This preliminary calculation of quality indicators allows for efficient filtering and validation, reducing false positives without requiring extensive post-assay analysis time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system dynamically adjusts assessment parameters and confidence thresholds based on the specific assay conditions and data quality observed. By adapting statistical parameters to the actual experimental context, the system maintains high diagnostic reliability while optimizing analysis time through intelligent parameter selection rather than fixed, overly conservative settings.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces false-positive rates, providing more accurate and reliable diagnostic methods for diseases associated with abnormal gene copy numbers, enabling better disease detection and carrier identification.

Implementation Method 1

the detectable signals are fluorescent signals, and the level of the fluorescent signals for the target locus or the one or more reference loci is detected at each amplification cycle of the RT-PCR

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS9361426B2Copy number analysis of genetic locus
Publication Date: 2016.06.07 ESOTERIX GENETIC LABORATORIES LLC
  • US9361426B2 patent drawing
  • US9361426B2 patent drawing
  • US9361426B2 patent drawing

AI summary

Systems and methods for analyzing copy number of a target locus, detecting a disease associated with abnormal copy number of a target gene or a carrier thereof.